ArticleFrontiers in pharmacology2020

Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience.

Aurélien Mary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.